D
TriSalus Life Sciences, Inc. TLSI
$5.10 $0.173.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -91.32% 21.44% 71.64% -61.00% 69.00%
Total Depreciation and Amortization -14.95% -1.71% -0.52% 8.33% 29.33%
Total Amortization of Deferred Charges -3.75% -- -- -- --
Total Other Non-Cash Items 160.99% 46.20% -84.07% 64.05% -220.30%
Change in Net Operating Assets 78.24% 431.06% -88.03% 31.97% -426.84%
Cash from Operations 45.46% 58.60% 37.81% 49.93% -45.32%
Capital Expenditure 255.00% -1,042.42% 86.56% 5.06% -93.55%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 255.00% -981.82% 86.56% 84.80% -100.00%
Total Debt Issued -100.00% -- -- -- --
Total Debt Repaid 95.24% -222.73% 13.64% 0.00% 0.00%
Issuance of Common Stock 517.33% -91.14% 3,444.71% 20,775.00% 22,443.75%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 40.26% -- 100.00% -100.00% --
Cash from Financing -20.30% 209.92% 6,862.79% -85.53% 305.95%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 7.83% 157.32% 70.93% -129.71% 536.99%